BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1992877)

  • 1. Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative Group.
    Henry-Amar M; Friedman S; Hayat M; Somers R; Meerwaldt JH; Carde P; Burgers JM; Thomas J; Monconduit M; Noordijk EM
    Ann Intern Med; 1991 Mar; 114(5):361-5. PubMed ID: 1992877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin disease.
    Friedman S; Henry-Amar M; Cosset JM; Carde P; Hayat M; Dupouy N; Tubiana M
    Am J Hematol; 1991 Aug; 37(4):253-7. PubMed ID: 1858782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease.
    Friedman S; Henry-Amar M; Cosset JM; Carde P; Hayat M; Dupouy N; Tubiana M
    J Clin Oncol; 1988 Apr; 6(4):596-602. PubMed ID: 3357004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of erythrocyte sedimentation rate in clinical stages I-II of Hodgkin's disease.
    Tubiana M; Henry-Amar M; Burgers MV; van der Werf-Messing B; Hayat M
    J Clin Oncol; 1984 Mar; 2(3):194-200. PubMed ID: 6366151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.
    Josting A; Franklin J; May M; Koch P; Beykirch MK; Heinz J; Rudolph C; Diehl V; Engert A
    J Clin Oncol; 2002 Jan; 20(1):221-30. PubMed ID: 11773173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy results in laparotomy-staged Hodgkin's disease.
    Verger E; Easton D; Brada M; Duchesne G; Horwich A
    Clin Radiol; 1988 Jul; 39(4):428-31. PubMed ID: 3180656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma.
    Krebs L; Amorin S; Brice P; Guillerm S; Menard J; Hennequin C; Quéro L
    Strahlenther Onkol; 2017 Feb; 193(2):116-124. PubMed ID: 27316376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL).
    Haase R; Vilser C; Mauz-Körholz C; Hasenclever D; Kluge R; Ruschke K; Borkhardt A; Seeger K; Lehrnbecher T; Kulozik A; Rößler J; Burdach S; Jürgens H; Körholz D
    Klin Padiatr; 2012 Oct; 224(6):377-81. PubMed ID: 23047832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].
    Bień E; Balcerska A
    Med Wieku Rozwoj; 2004; 8(4 Pt 2):1081-9. PubMed ID: 15951603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABVD or BEACOPP
    Fermé C; Thomas J; Brice P; Casasnovas O; Vranovsky A; Bologna S; Lugtenburg PJ; Bouabdallah R; Carde P; Sebban C; Eghbali H; Salles G; van Imhoff GW; Thyss A; Noordijk EM; Reman O; Lybeert MLM; Janvier M; Spina M; Audhuy B; Raemaekers JMM; Delarue R; Anglaret B; de Weerdt O; Marjanovic Z; Tersteeg RJHA; de Jong D; Brière J; Henry-Amar M; ;
    Eur J Cancer; 2017 Aug; 81():45-55. PubMed ID: 28601705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multivariate analysis of prognostic factors in early stage Hodgkin's disease.
    Tubiana M; Henry-Amar M; van der Werf-Messing B; Henry J; Abbatucci J; Burgers M; Hayat M; Somers R; Laugier A; Carde P
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):23-30. PubMed ID: 3881375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease prognosis: a directly predictive equation.
    Gobbi PG; Cavalli C; Federico M; Bertoloni D; Di Prisco UA; Rossi A; Silingardi V; Mauri C; Ascari E
    Lancet; 1988 Mar; 1(8587):675-9. PubMed ID: 2895213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current approaches to the management of pediatric Hodgkin lymphoma.
    Freed J; Kelly KM
    Paediatr Drugs; 2010 Apr; 12(2):85-98. PubMed ID: 20218745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group.
    Wirth A; Grigg A; Wolf M; Goldstein D; Johnson C; Davis S; Dutu G; Kypreos P; Smith C; Kneebone A; Herzberg M; Joseph D; Catalano J; Roos D; Stone J; Reynolds J
    Leuk Lymphoma; 2011 May; 52(5):786-95. PubMed ID: 21314490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
    Chronowski GM; Wilder RB; Tucker SL; Ha CS; Sarris AH; Hagemeister FB; Barista I; Hess MA; Cabanillas F; Cox JD
    Cancer; 2002 Dec; 95(12):2534-8. PubMed ID: 12467067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
    Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
    Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relapse in Hodgkin lymphoma].
    Filatova LV; Tarasenkova AA; Gershanovich ML; Semiglazov TIu
    Vopr Onkol; 2012; 58(2):265-74. PubMed ID: 22774536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
    Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
    Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.